In contrast to studies in women, male osteoporosis is poorly understood and strictly related to advancing age. Among the first antiresorptive substances used in the prevention and treatment of osteoporosis is calcitonin (CT), a hypocalcemic hormone that potently inhibits osteoclastic bone resorption. Natural CT is produced and secreted by thyroid C-cells. The other endocrine population of thyroid cells produces thyroid hormones (TH), which also affect bone turnover. The aim of this study was to evaluate the influence of salmon CT on trabecular bone microarchitecture with special reference to effects on the structure and function of both CT-and TH-producing thyroid cells in orchidectomized (Orx) middle-aged rats. Twenty-four male Wistar rats aged 15 months were randomly divided into Orx and sham-operated (SO) groups. One group of Orx animals received (s.c.) synthetic salmon CT (Orx + CT; 100 IU kg À1 b.w.) subcutaneously every second day for 6 weeks. The second Orx group and SO rats were given the same volume of vehicle alone by the same schedule. Trabecular bone histomorphometrical parameters were: cancellous bone area (B.Ar), trabecular thickness (Tb.Th), trabecular number (Tb.N) and trabecular separation (Tb.Sp) were obtained with an IMAGEJ public-domain image-processing program. The peroxidase-antiperoxidase method was applied for localization of CT in C-cells. Anti-human CT antisera served as the primary antibodies. For immunohistochemical characterization of vascular endothelial growth factor (VEGF) in thyroid tissue, rabbit antisera against human VEGF, served as primary antibodies. CT-immunopositive thyroid C-cells, thyroid follicular epithelium, interstitium and colloid were evaluated morphometrically. Blood serum samples were analyzed for CT, osteocalcin (OC), and thyroxine (T 4 ), and calcium (Ca
Introduction
Osteoporosis is a skeletal disorder characterized by unbalanced bone remodeling activity. This causes microarchitectural deterioration of the bone and progressive decrease in bone density. Although this disease affects both sexes, age-related bone loss in men is much less investigated than in women. Unlike menopausal women, there is no dramatic decline in sex hormone levels in men, but the continuous slow reduction in circulating androgens is associated with bone loss (Swerdloff & Wang, 2002) . Male osteoporosis is related to advancing age and starts later in life than in women (Rochira et al. 2006) . Although osteoporosis in males is caused by androgen deficiency, estrogens have a greater bone-protecting effect than testosterone. Most of the estrogen in men is derived from aromatization of androgens by the enzyme aromatase in different tissues (Simpson & Dowsett, 2002) . Even though the number of studies on the pathophysiology of bone in men has increased in recent years, this phenomenon remains poorly understood. Hence, there is a need for additional research to better understand this condition in men.
Different antiresorptive and anabolic agents have been used to prevent and treat osteoporosis. One of the first antiosteoporotic therapeutics was calcitonin (CT), a hypocalcemic peptide hormone that regulates serum calcium levels. It acts as an antiresorptive agent by directly inhibiting osteoclast-mediated bone resorption and by increasing calcium excretion through the kidney (Warshawsky et al. 1980) . Among synthetic CT preparations from different species, salmon CT is the most widely employed in clinical practice due to its much greater potency compared with human CT (Azria et al. 1995) . Treatment with salmon CT increased bone mineral density, enhanced bone biomechanical properties and accelerated healing of bone fractures in osteoporotic rat models (Li et al. 2007; Bulbul et al. 2008) .
Mammalian CT is produced by thyroid gland C-cells (Pearse, 1966) , the activity of which was suggested to be regulated by circulating gonadal hormone concentrations (Foresta et al. 1985; Greenberg et al. 1986 ). Sex steroid-deficient gonadectomized rats are animal models of osteoporosis because thyroid C-cell activity is inhibited in both females (Sakai et al. 2000; Filipovi c et al. 2003) and males (Lu et al. 2000; Filipovi c et al. 2007 ). On the other hand, thyroid follicular cells synthesize and secrete thyroxine and triiodothyronine, which have important roles in skeletal homeostasis and bone mass regulation (Yen, 2001) . Thyroid hormones (TH) activate bone resorption (Kanatani et al. 2004) . Sex steroids regulate TH homeostasis, which may change during aging. In the rodent model of osteoporosis the effects of sex hormone deficiency after gonadectomy may differ depending on age and gender (Banu et al. 2001 (Banu et al. , 2002 So si c-Jurjevi c et al. 2012) .
There is little available information about the use of CT in the treatment of male osteoporosis, although CT has shown beneficial effects on bone in postmenopausal osteoporosis (Gruber et al. 1984) . The pathogenesis of male osteoporosis differs from that of postmenopausal osteoporosis and agents that are effective in women may not be effective in men (Trovas et al. 2002) . Since there are few studies about the pathogenesis of male osteoporosis, additional research is needed to gain an understanding of the mechanisms of action of some remedies used to treat this bone disease. Considering that both CT and TH produced by the thyroid play important roles in the regulation of bone mass, the aim of this study was to determine the effects of exogenous CT administration on trabecular bone microarchitecture but with special reference to structural and functional changes and potential interactions of the two different thyroid endocrine cell populations in a rat model of male osteoporosis.
Materials and methods

Animals and experimental design
Male Wistar rats were housed at the Institute for Biological Research, Belgrade, Serbia, and maintained with free access to food and water in a 12/12 h light/dark cycle at 22 AE 2°C. Twenty-four (15-monthold) male rats were divided into three groups: sham operated control (SO), orchidectomized control (Orx), and Orx rats treated with calcitonin (Orx + CT). The animals were bilaterally orchidectomized or sham operated under ketamine anesthesia (15 mg 
Bone histomorphometry
Rat proximal tibia samples were excised, cleaned of soft tissue and fixed in Bouin's solution for 5 days. After fixation, the specimens were decalcified in 20% EDTA (ethylenediaminetetra-acetic acid disodium salt) solution in distilled water, pH 7.4, for 2-4 weeks with renewal of the solution every second day. Thereafter, tibias were routinely processed and embedded in paraplast. Each tissue block was placed in a rotation microtome (RM 2125; Leica, Germany) with microtome blades for hard section (Sakura Finetek, Japan) and cut longitudinally followed by staining using the Azan method, as previously described (Filipovi c et al. 2007 ).
Histomorphometry was performed with an IMAGEJ public-domain image-processing program. The area of the secondary spongiosa of the analyzed metaphyseal region included the part within 1 mm distal to the epiphyseal growth plate. The histomorphometric parameters and the calculations employed are those described in the Report of the American Society for Bone and Mineral Research Committee Histomorphometry Nomenclature (Parfitt et al. 1987) . The data automatically obtained by the image analysis system were used to calculate the cancellous bone area (B.Ar) and cancellous bone perimeter (Evans et al. 1994) . Trabecular thickness (Tb.Th), trabecular number (Tb.N) and trabecular separation (Tb.Sp) were derived from these parameters as described earlier (Filipovi c et al. 2007 ).
Immunohistochemistry
The thyroid lobes were excised, fixed in Bouin's solution for 24 h and embedded in paraplast. A rotatory microtome are used for cutting 5-lm-thick longitudinal sections of fixed thyroid tissue. The peroxidase-antiperoxidase (PAP) method was used for immunohistochemical detection of CT in thyroid C-cells (Sternberger et al.1970) . Anti-human CT antisera (Dakopatts, Copenhagen, Denmark, Lot No. 020) diluted 1 : 500 served as the primary antibodies.
For immunohistochemical characterization of vascular endothelial growth factor (VEGF) in thyroid tissue, rabbit antisera against human VEGF (Abcam, Cambridge, UK, Lot No. GR247559-1) diluted 1 : 100 and applied overnight at 4°C, served as primary antibodies.
Antigen-antibody complexes were visualized by incubating tissue sections with diaminobenzidine tetrahydrochloride (DAB; Dakopatts, Glostrup, Denmark). The incubated sections were counterstained with hematoxylin and mounted with DPX (Sigma-Aldrich, Barcelona, Spain).
Stereological analysis
Thyroid gland sections were stereologically analyzed by a pointcounting method (Weibel 1979) . We determined the mean volume (Vc; lm 3 ) and relative volume density (volume of C-cells per unit volume of thyroid gland; Vvc; %) of calcitonin immunoreactive thyroid C-cells. Also, the relative volume density (Vv; %) of the corresponding thyroid tissue components (follicular epithelium, interstitium and colloid), defined as the ratio of this component in a volume unit, was calculated. All parameters were measured in 50 test fields of thyroid gland using the M42 multipurpose test grid inserted into the ocular of a Zeiss light microscope (Jena, Germany), at a total magnification of 10009 for C cells and 4009 for other thyroid components.
Serum and urine biochemical parameters
Serum samples from all experimental groups were used for determination of osteocalcin (OC), CT and thyroxine (T 4 ) concentrations. The 24-h urine collections from each group were used for measurement of calcium (Ca 2+ ) concentration. Serum CT levels were determined immunochemiluminometrically (Nichols, USA) using a mouse monoclonal antihuman CT antibody marker with acridium ester. The luminescence was quantified with a semiautomated MLA 1 chemiluminescence analyzer (Ciba-Corning). Serum concentrations of T 4 were determined by ELISA (HUMAN, Wiesbaden, Germany). All serum samples were measured in duplicate within a single assay. The intra-assay coefficient of variation was 8-8.7%. Serum OC levels were determined by electrochemiluminescence using a Roche Elecsys 2010 immunoassay analyzer (Roche Diagnostics GmbH, Mannheim, Germany). Serum Ca and P levels and urinary Ca 2+ concentration were determined on a Hitachi 912 analyzer (Roche Diagnostics GmbH).
Statistical analysis
The data were analyzed with STATISTICA 6.0 software (Statsoft, Tulsa, OK, USA). The Kolmogorov-Smirnov test was used to determine potential deviation from normal distribution, followed by one-way analysis of variance (ANOVA). Duncan's multiple range test was employed for post hoc comparisons between groups. Differences between mean values were considered to be significant at P < 0.05. The data are presented as means AE standard error of the mean (SEM).
Results
Trabecular bone microarhitecture after calcitonin treatment
We assessed the effect of CT treatment on bone structure parameters in the proximal tibia metaphysis of Orx middleaged rats. Previously, we showed that trabecular bone mass declined markedly after Orx (Filipovi c et al. 2007 ). In the CT-treated Orx group, trabecular bone mass was increased, as reflected by numerous well developed trabeculae when compared with proximal tibiae from untreated Orx rats. Histological features of trabecular bone tissue after CT application were similar to the trabecular bone microarchitecture seen in control SO animals (Fig. 1A-C) . After CT treatment, B.Ar, TbTh and TbN were increased by 176, 35 and 28% (P < 0.05), respectively; but Tb.Sp had diminished by 27% (P < 0.05) when compared with the Orx group. There were no significant differences in microstructural parameters of trabecular bone after calcitonin treatment in SO animals (Fig. 1D ).
Thyroid C-cells after calcitonin treatment
Calcitonin-producing thyroid C-cells in SO animals were numerous and distributed as large clusters with lightcolored granular cytoplasm ( Fig. 2A) . After Orx, C-cells with darker cytoplasm were much less abundant than in the SO group (Fig. 2B) . The majority of C-cells in Orx animals treated with CT appeared as less numerous individual cells with a thin layer of dark cytoplasm around the nucleus (Fig. 2C) . Stereological analysis showed that treatment of Orx rats with CT significantly decreased both Vc and Vvc by 14 and 15% (P < 0.05), respectively, when compared with the control Orx rats. Also, CT treatment markedly reduced both parameters (Vc and Vvc) by 26% (P < 0.05) in relation to SO (Fig. 2D) . We have already reported a significant decrease in Vc and Vvc of thyroid C-cells in Orx rats when compared with SO animals (Filipovi c et al. 2007 ).
Thyroid follicular cells and VEGF immunoreactivity after calcitonin treatment
Within thyroid tissue, TH-producing cells are organized in angiofollicular units, composed of follicles and surrounding vasculature. Follicles vary in size and shape, in correlation with their function in hormone production. In SO controls, the follicular epithelium was mainly cuboidal, surrounding relatively large portions of luminal colloid. Numerous C-cells characterized by large, light nuclei and usually grouped in large clusters adjacent to thyroid follicles could be easily distinguished on hematoxylin and eosin-stained sections (Fig. 3A) . Orchidectomy of middle-aged males did not induce significant histomorphometric changes in thyroid follicles when compared with age-matched SO controls (Fig. 3B) . However, after CT treatment the follicles were extended and filled with more colloid than in either Orx or SO controls (Fig. 3C) . Stereological analysis showed that the relative V V of the colloid was 27% higher (P < 0.05), whereas V V of the follicular epithelium was 13% lower (P < 0.05) in the Orx+CT group than the value obtained for the Orx group (Fig 3D) .
VEGF is a major paracrine factor that regulates angiogenesis and vascular permeability and we studied VEGF-immunopositivity as an indirect measure of the activity of the vascular component within angiofollicular units. VEGFimmunopositivity was granular and uniformly distributed in the cytoplasm of thyrocytes, being weakest in the Orx-CT group, which had a flattened follicular epithelium (Fig. 4) .
Serum and urine parameters after calcitonin treatment
Administration of salmon CT to Orx rats lowered serum OC and urinary Ca 2+ concentrations by 61 and 63% (P < 0.05), respectively, in comparison with the Orx group (Fig. 5A,B) . Serum CT concentration was elevated by 247 and 60% (P < 0.05), respectively, after CT treatment in comparison with the Orx and SO groups (Fig. 5C ), whereas serum T 4 was 17% lower (P < 0.05) than in Orx rats (Fig. 5D) . We have already shown that Orx markedly decreased serum CT and urinary Ca 2+ concentrations, whereas serum OC was higher than in the control SO animals (Filipovi c et al. 2007 ).
Discussion
Unlike postmenopausal osteoporosis, the pathogenesis of male osteoporosis and mechanisms of action of anti-osteoporotic therapeutics are very poorly understood. As a potent inhibitor of osteoclastic bone resorption and promoter of bone fomation, the hypocalcemic hormone, CT, has been used to treat many bone disorders including osteoporosis (Arisawa et al. 2008) . Natural CT is a 32-amino acid peptide hormone secreted by thyroid C-cells (Pearse, 1966) . TH-producing thyroid follicular cells also have marked effects on bone tissue metabolism (Yen, 2001) . Besides trabecular bone, the main purpose of this study was to examine the effect of salmon CT on the structure and function of both thyroid C-cells and follicular cells, as their hormone products each have significant roles in bone mass regulation. As a model of male osteoporosis we evaluated the effect of salmon CT treatment on trabecular bone microarchitecture in middle-aged Orx rats. Previously, we demonstrated a reduction of trabecular bone mass in androgen-deficient male rats (Filipovi c et al. 2007 ). Here we found that treatment with salmon CT markedly improved bone structure parameters. Thus, B.Ar, Tb.Th and Tb.N were increased but Tb.Sp was decreased in relation to values for the control Orx rats. Moreover, serum OC and urinary Ca 2+ concentrations were significantly lower than in Orx rats. These results are in line with those of others using rats, which confirms the bone-protective effects of salmon CT in this species (Li et al. 2007; Bulbul et al. 2008 ) and the few studies on the effect of this hormone on bone turnover in osteoporotic men (Trovas et al. 2002) . Calcitonin is a potent inhibitor of osteoclastic bone resorption and this action is mediated in part by binding to osteoclast membrane receptors (Nicholson et al. 1986 ). This hormone directly causes loss of the ruffled border of osteoclasts in vitro (Chambers & Magnus, 1982) , reduces osteoclast number and motility (Zaidi et al. 1990; Gao & Yamaguchi, 1999) and inhibits osteoclast secretory activity, such as synthesis and release of tartrate-resistant acid phosphatase (Yumita et al. 1991) . In addition to osteoclasts, CT interacts with osteoblasts by inducing their proliferation (Villa et al. 2003) and may prevent osteoblast and osteocyte apoptosis (Plotkin et al. 1999 ). Also, CT is able to induce increased secretion of insulin-like growth factor in osteoblasts (Farley et al. 2000) . The fact that CT receptors are expressed on osteoblasts indicates that CT acts through its own receptors (Villa et al. 2003) . In addition to the influence of salmon CT on trabecular bone microarchitecture, we investigated its effects on the activity of CT-and TH-secreting thyroid cell populations. Sex steroid deficiency in gonadectomized models of osteoporosis has already been shown to affect thyroid C-cell structure, and reduce the synthesis and release of CT and TH homeostasis in female and male rats (Banu et al. 2001 (Banu et al. , 2002 Filipovi c et al. 2003 Filipovi c et al. , 2007 So si c-Jurjevi c et al., 2012) .
In this study, we demonstrated that treatment of Orx rats with salmon CT further decreased the already reduced Vc and Vvc of thyroid C-cells, whereas serum CT was elevated due to Orx. This inhibitory effect of exogenous CT on rat thyroid C-cell function and proliferation was described earlier (Morimoto et al. 1984; Mori et al. 2003) . Exogenous CT suppresses C-cell function probably by involving a negative feedback mechanism. The mRNA for CT receptors has been shown to be expressed in both tissue and cell lines of human medullary thyroid carcinoma (Frendo et al. 1998a, b) . Therefore, CT may act directly via its own receptors on C-cells (Mori et al. 2003) . Under our experimental conditions, CT treatment also affected the overall structure of rat thyroid glands. Thus, the large accumulations of colloid in the follicles, low cuboidal epithelium of TH-producing follicular cells, diminished levels of T 4 and weaker VEGFimmunopositivity compared with control Orx rats indicated thyroid gland hypoactivity. Published data regarding the effect of CT treatment on thyroid cells, especially thyroid follicular cells, are scarce and often contradictory. Some data support an indirect action of exogenous CT on the activity of TH-producing thyroid cells through reduced TSH concentration in both humans (Leicht et al. 1974 ) and rats (Ishii et al. 1991) . Also, processes such as thyroid growth are inhibited by CT (Rybicka et al. 1992) . It is possible that Ccells influence the activity of thyroid follicular cells via a paracrine pathway involving regulatory peptides. Thus, some effects, such as the stimulative action of serotonin secreted from C-cells on TH release (Kali snik et al. 1990 ), can be suppressed by inhibiting the thyroid C-cell population.
It is known that changes in TH status can alter bone metabolism (Murphy & Williams, 2004) . Thyroid hormones stimulate osteoclastic bone resorption directly through nuclear TH receptors a and b (Mundy et al. 1976; Kanatani et al. 2004) . In vitro data indicate that TH affect bone either by direct action on osteoclasts or by activating osteoblasts, which then release a receptor activator for nuclear factor kappa-B ligand (Britto et al. 1994) . The thyroid gland hypoactivity and marked decrease in serum T 4 after salmon CT treatment found here suggest that exogenous CT, in addition to directly stimulating trabecular bone formation, may affect the activity of the TH-producing cell population in the thyroid. Mechanisms by which CT act on the thyroid gland are still unclear. Thyroid C-cells are mostly localized in central regions of the thyroid gland lobes, where TH synthesis and secretion seem to be higher than in the periphery. It is probable that regulatory peptides produced by C-cells may participate in controlling thyroid activity by a direct paracrine route. Consequently, the possible mechanism of action may include this potential paracrine stimulation of follicular cells by thyroid C-cells. In our experimental conditions, the exogenous CT induced strong inhibition of thyroid C-cells and may be associated with the absence of paracrine stimulation of thyroid follicular cells.
In summary, in our animal model of male osteoporosis, salmon CT treatment decreased bone turnover and deterioration of bone structure. However, exogenous CT strongly inhibited thyroid C-cells, accompanied by an influence on structural and functional features of thyroid follicular cells. Thyroid follicular cell hypoactivity after exogenous CT application may additionally contribute to the beneficial effect of such treatment on trabecular bone mass. This is the first report which opens the possibility, among others, that, besides direct action on the skeleton, exogenous CT may affect trabecular bone structure indirectly through changes in thyroid follicular cell activity caused by potential inhibition of C-cell paracrine regulation.
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